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Pneumococci & streptococci
Testing and clinical implications 
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Key questions
 What is the clinical importance of
streptococci ?
 What are their resistances to 
antimicrobial agents ?
 What are the clinical implications 
for the clinical microbiology lab ?
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STREPTOCOCCUS PNEUMONIAE
 Lower respiratory tract 
infections, pneumonia
 the single most important 
bacterial pathogen
 Otitis media 
 Main cause in children
 Hearing impairment if 
reccurrence
 Meningitis
 Life-threatening (children, elderly)
 Neurologic sequelae
 Sepsis
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The challenging pathogens
In hospital












 Salmonella (ESBL, FQ)
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STREPTOCOCCUS PNEUMONIAE
 Emergence of antimicrobial resistance
 Treatment failures
 Increased morbidity/mortality
 Increased duration of diseases
 Costs
Key role for laboratory :
To recognize « Resistant » organisms !!
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Global antibiotic resistance
in S.pneumoniae
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Global antibiotic resistance
in S.pneumoniae
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S.pneumoniae:
Mechanisms of resistance
 Resistance to Penicillin
 Modification of Penicillin Binding Proteins
 Qualitative & quantitative alteration of the targets
 Transformation and/or stepwise chromosomally
mediated mutations; genes < oral streptococci
 Decreased susceptibility to all β-lactams
 Ceph. III and amoxicillin less affected
 Clonal spread AND local emergence
 50 % co-resistance to other agents 
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S.pneumoniae: 
Mechanisms of resistance
 Resistance to Macrolides
 Alteration of ribosomal methylase (ermB gene)
 Constitutive or inducible (D test)
 MLSB phenotype
 ATP-dependant efflux pump (mefE gene)
 Resistance to fluoroquinolones
 Chromosomal mutations of gene encoding for
 Topoisomerase IV (parC, parE)
 DNA gyrase (gyrA, gyrB)
 Efflux 




 Penicillin : NOT reliable !!
 Oxa screen
 NCCLS 1 µg disk (S >= 20 mm)
 SFM 5 µg disk (S >= 26 mm) 
 No dicrimination between I and R isolates
 False R and a few false S
Need for true MICs




 Susceptibility (MIC <= 0.064 mg/L) correlates
with clinical outcome with standard dosages
 I
 Intermediate susceptibility (MIC <= 0.12 - 1 
mg/L) requires a high penicillin dose for clinical
outcome
 R
 Resistance (MIC >= 2 mg/L) necessitates
alternative therapy
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Susceptibility/Resistance
testing methods
 MICs in routine
 Automated microdilution system
 Vitek 2 (BioMérieux)
 Risk of underestimation of R
 Etest
 The easiest and affordable
 Detects subtle decreases in S
 Validated, « reference method »
 Directly on Gram positive CSF 

















New FQ if non-CSF
Disc
Oxacillin 1µg
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Streptococcus pyogenes
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Streptococcus pyogenes
 Pharyngitis and asymptomatic carriage (1-70%)
 Scarlet fever
 Erysipelas









 Rheumatic fever, poststreptococcal glomerulonephritis
The « flesh eating » bacteria




 Alternatives may include
 Macrolides and certain cephalosporins; 
 Vancomycine for pen-allergic patients with
serious infections
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Streptococcus pyogenes
 Penicillin
 GAS remain 100 % Sensitive
 = drug of choice
 S-testing not necessary
 But, reduced efficacy in severe GAS 
infection
 High inoculum
 Decrease in expression of Penicillin Binding 
Protein (PBP) by GAS in stationary phase
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Streptococcus pyogenes
 In severe infections: Clindamycin more 
effective
 Not affected by inoculum or stationary phase
 Inhibits synthesis of bacterial toxins
 Facilitates phagocytosis of GAS by inhibiting synthesis of M 
protein
 Suppresses PBP Synthesis  degradation
 Longer post-antibiotic effect/penicillin
 Resistance to Macrolides (+/- 10%)
 Alteration of ribosomal methylase (ermB gene)
 MLSB phenotype, constitutive
 Efflux pump (mefA gene)




• EOD & LOD
 Infections during pregnancy
 Adult’s infections
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Risk factors for neonatal EOD
 Vaginal Colonization
 Obstetrical risks: 
 Prolonged rupture of membranes, 
Prematurity, Intrapartum fever
 GBS bacteriuria
 Previous infant with GBS 
infection
 Immunologic risks: 
 Low level specific IgG, etc
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Labor & delivery ward
pm-chu lg - May 2004 23
Intrapartum antibio-prophylaxis
(CDC 2002, Belgian HC 2003)
 Penicillin G
 5 millions U, IV initial dose, + 2,5 
millions U IV every 4 hours until delivery
 Ampicilline
 2 g IV initial dose, + 1 g IV every 4 h until delivery
 Acceptable alternative, but extended spectrum, may
select R strains
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Intrapartum antibio-prophylaxis
In case of penicillin-allergy
(CDC 2002, Belgian HC 2003)
 Patient at low risk for anaphylaxis
 Cefazolin
 Patient at high risk for anaphylaxis
 Clindamycin
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Therapeutic options 
 Empiric
 Ampicillin + aminoglycoside
 When confirmed
 Penicilline + aminoglycoside (max 3-5 days)
 Then Penicillin for 10 to 28 days









Pen Ampi Céph.I Ery/Clin
Sensible Résistant
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GBS Penicillin susceptibility
and tolerance
No tolerance was observed :
79.3 % of  isolates had an MBC/MIC = 1
19 % of  isolates had an MBC/MIC = 1.5
1.7 % of  isolates had an MBC/MIC = 2 
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β-hemolytic streptococci and
streptococcus « viridans »
 Tolerance to β-lactams
 High MBCs despite low MICs
 Progressive decreases in S to Penicillin in    
β-hemolytic streptococci
 Pen R in viridans group
 Increasing macrolide, trimeth/sulfa and FQ R
MICs needed for serious infections 
or critical patients
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β-hemolytic streptococci and
streptococcus « viridans »
 Disc diffusion 
 Penicillin and FQ 
 Only for β-hemolytic streptococci
 Microdilution and automated systems
 Growth supplement, CO2, etc
 Not adapted, except for GBS
 Etest
 Easy, affordable, convenient
 Media and atmosphere adapted
 Detects subtle decreases in S
 Directly on Gram positive CSF 















(New FQ if non-CSF)
Blood or sterile site or « critical » patient
* Pen S = β-lactams S
** or Ceftriaxone
GAS, GBS, GCS & 
GGS large colonies
